Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy

Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy

Patients with advanced pancreatic ductal adenocarcinoma (PDAC) have a dismal prognosis. We aimed to find a prognostic protein signature for overall survival (OS) in patients with advanced PDAC, and to explore whether early changes in circulating-protein levels could predict survival. We investigated...

Full description

Bibliographic Details
Main Authors: Sidsel C. Lindgaard, Emil Maag, Zsófia Sztupinszki, Inna M. Chen, Astrid Z. Johansen, Benny V. Jensen, Stig E. Bojesen, Dorte L. Nielsen, Zoltan Szallasi, Julia S. Johansen
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Cancers
Subjects:
biomarkers
inflammation
pancreatic cancer
prognosis
protein arrays
Online Access:https://www.mdpi.com/2072-6694/14/13/3250

Internet

https://www.mdpi.com/2072-6694/14/13/3250

Similar Items